How much funding has ExploRNA Therapeutics raised?

ExploRNA Therapeutics has raised $814K in total funding, most recently a Venture Round.

Who are ExploRNA Therapeutics's investors?

ExploRNA Therapeutics's investors include Bill & Melinda Gates Foundation.

What industry is ExploRNA Therapeutics in?

ExploRNA Therapeutics operates in deep tech.

How many employees does ExploRNA Therapeutics have?

ExploRNA Therapeutics has 11-50 employees.

ExploRNA Therapeutics

Advancing mRNA as a therapeutic platform

deep tech

Employees: 11–50
Business Model: B2B
Website: explorna.com

Total Funding: $814K
Last Round: $814K Venture RoundDec 2022
Rounds: 2

About

ExploRNA Therapeutics develops next-generation mRNA therapeutics through innovations in mRNA cap analog chemistry. Spun out of the University of Warsaw, the company creates proprietary cap technologies—including AvantCap and ExploCap—that enhance mRNA stability and protein expression in vivo. ExploRNA partners with pharmaceutical companies to advance mRNA therapeutic platforms and programs across disease areas.

Summary

ExploRNA Therapeutics is a deep tech company. It has raised $814K in total across 2 rounds, most recently a $814K Venture Round round in Dec 2022. Investors include Bill & Melinda Gates Foundation.